
Loading, please wait...

Loading, please wait...

Recently, the United Nations Secretary-General nominated a distinguished digital governance expert, Dr Rajendra Pratap Gupta, to the Multistakeholder Advisory Group (MAG) of the Internet Governance Forum (IGF).
Consequently, this nomination highlights India's growing leadership in global digital policy and telemedicine development.
Moreover, Dr Gupta currently serves as the chair of both the Health Parliament and the Academy of Digital Health Sciences.
In this prestigious global role, Dr Gupta will actively advise the Secretary-General on complex internet policies.
Furthermore, the MAG specifically shapes the program, strategic direction, and overall multistakeholder dialogue of the forum.
Consequently, his extensive experience as a former advisor to the Union Health Minister will greatly benefit international frameworks.
Indeed, digital public infrastructure and artificial intelligence require coordinated global regulations to ensure safety.
Crucially, digital governance directly influences how modern clinical technologies, such as telehealth platforms, expand in developing nations.
Therefore, this appointment serves as a major milestone for Indian healthcare professionals advocating for digital health standards.
Additionally, Dr Gupta expressed his deep gratitude for this opportunity to collaborate on building an inclusive and secure digital future.
Ultimately, global cooperation will foster a much safer environment for healthcare innovations to thrive.
Q1: What is the Multistakeholder Advisory Group (MAG)?
The MAG is a prestigious body constituted to advise the UN Secretary-General on global Internet governance and digital policy issues while shaping the program of the Internet Governance Forum.
Q2: Why is Dr Rajendra Pratap Gupta's nomination significant for digital health?
As a leading digital health expert and former advisor to India's Union Health Minister, his presence on the global advisory group ensures that digital health policy and medical tech innovations receive global strategic attention.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The UN Secretary-General has nominated Indian policy leader Dr Rajendra Pratap Gupta to the Multistakeholder Advisory Group of the Internet Governance Forum...
3 months ago

A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today